PHARMACEUTICAL COMPOSITION COMPRISING LEVOCARNITINE AND DOBESILATE,申请号EP20110800122-传众专利搜索

PHARMACEUTICAL COMPOSITION COMPRISING LEVOCARNITINE AND DOBESILATE

申请公布号：EP2589382(A1)

申请号：EP20110800122

申请日期：2011.06.10

申请公布日期：2013.05.08

申请人：

LIAONING SEBEST PHARMACEUTICAL CO., LTD.;NANKAI SHARE PHARMACEUTICAL CO., LTD.;XIZANG LINZHI PARKSON PHARMACEUTICAL CO., LTD.;TIANJIN NANKAI SHARE PHARMACEUTICAL SCIENCE & TECHNOLOGY CO., LTD.

发明人：WANG, YONG;ZHAO, XIN;CHEN, MO;TIAN, NING;WANG, SHUJUN

分类号：A61K31/205;A61K31/095;A61K31/185;A61P9/00;A61P9/10;A61P13/12

主分类号：A61K31/205

摘要：<p>A pharmaceutical composition comprising levocarnitine and dobesilate is provided. Also provided are a method for regulating the level of serum creatinine and/or blood urea nitrogen and a method for treating and/or preventing the diseases influencing renal function, for example, including but not limiting to various primary, secondary nephritis, renal lesions, renal insufficiency, nephritic syndrome, even renal failure, uremia, as well as the complications induced by the diseases and/or disorders influencing renal function for example, such as cardiovascular diseases, diabetes and the like.</p>